Skip to main content

Understanding the Mechanisms of Cure in Acute Myeloblastic Leukaemia: Towards a Modern Immunotherapy

  • Conference paper
Acute Leukemias

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 34))

  • 67 Accesses

Abstract

The published literature suggests that less than 25% of patients with de novo acute myeloblastic leukaemia (AML), treated by intensive chemotherapy, are cured by this approach [1, 2]. Modest improvements have been claimed for treatment on high-dose cytosine arabinoside (HD-Ara-C) containing combinations [3] and in younger patients on the VAPA protocol [4]. As a rule more than 60% experience disease recurrence [5, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rees JKH, Gray RG et al. (1986) Lancet ii: 1236–1241

    Article  Google Scholar 

  2. Preisler HD, Anderson K, Cuttner J et al. (1987) Br J Haematol 71: 189–194

    Article  Google Scholar 

  3. Wolff SN, Herzig AW, Phillips GL et al. (1987) Semin Oncol 14: 12–17

    PubMed  CAS  Google Scholar 

  4. Weinstein JH, Mayer RJ, Rosenthal DS et al. (1983) Blood 62: 315–319

    PubMed  CAS  Google Scholar 

  5. Garson OM, Hagemcijer A, Sakurai M et al. (1989) Cancer Genet Cytogenet 40: 187–202

    Article  PubMed  CAS  Google Scholar 

  6. International Bone Marrow Transplant Registry (1989) Lancet i: 1119–1122

    Google Scholar 

  7. Gratwohl A, Hermans J, Barrett AJ et al. (1988) Lancet i: 1379–1382

    Google Scholar 

  8. Pollard, CM, Powles RL, Miller JL (1986) Lancet ii: 1343–1344

    Article  Google Scholar 

  9. Atkinson K, Biggs J, Dodds A et al. (1988) Aust NZ J Med 18: 587–593

    Article  CAS  Google Scholar 

  10. Maraninchi D, Gluckman E, Blaise D (1986) Lancet ii: 175–178

    Google Scholar 

  11. Weiden PL, Fluornoy N, Thomas ED et al. (1979) N Engl J Med 300: 1068–1073

    Article  PubMed  CAS  Google Scholar 

  12. Clift RA, Buckner CD, Appelbaum FR et al. (1990) Blood 76: 1867–1871

    PubMed  CAS  Google Scholar 

  13. Clift RA, Buckner CD, Appelbaum FR et al. (1990) Blood 76: 1867–1871

    PubMed  CAS  Google Scholar 

  14. Burnett AK, Hann IM, Robertson AG et al. (1988) Leukaemia 2: 300–303

    CAS  Google Scholar 

  15. Ash RC, Jasper D, Lawton CG et al. (1989) Blood 74(1): 163 (abstr)

    Google Scholar 

  16. Schattenberg A, De Witte T, Bar B et al. (1989) Bone Marrow Tansplant 4 [Suppl 1]: 111

    Google Scholar 

  17. Reittie JE, Gottlieb DJ, Heslop HE et al. (1989) Blood 73: 1351–1358

    PubMed  CAS  Google Scholar 

  18. Hercend T, Reinherz ELK, Meuer SC et al. (1983) Nature 301: 158–160

    Article  PubMed  CAS  Google Scholar 

  19. Price G, Brenner MK, Prentice HG et al. (1989) Br J Cancer 71: 189–194

    Google Scholar 

  20. Heslop HE, Gottlieb DJ, Reittie JE et al. (1989) Br J Haematol 72: 122–126

    Article  PubMed  CAS  Google Scholar 

  21. Kiyohara T, Taniguchi K, Kubota S et al. (1988) J Exp Med 168: 2355–2360

    Article  PubMed  CAS  Google Scholar 

  22. Leger O, Drexler HG, Reittie JE, et al. (1987) Br J Haematol 67: 273–279

    Article  PubMed  CAS  Google Scholar 

  23. Gottlieb DJ, Brenner MK, Heslop HE et al. (1989) Br J Cancer 60: 610–615

    Article  PubMed  CAS  Google Scholar 

  24. Gottlieb DJ, Prentice HG, Heslop HE et al. (1988) Blood 74: 2335–2342

    Google Scholar 

  25. Foa R, Fierro MT, Tosti S et al. (1990) Leuk Lymph 1: 113–117

    Article  Google Scholar 

  26. MacDonald D, Jiang YZ, Swirsky D et al. (1991) Br J Haematol 77: 43–49

    Article  PubMed  CAS  Google Scholar 

  27. Carron JA, Cawley JC (1989) Br J Haematol 73: 168

    Article  PubMed  CAS  Google Scholar 

  28. Foa R, Caretto P, Fierro NT (1990) Br J Haematol 75: 34–40

    Article  PubMed  CAS  Google Scholar 

  29. Geller RB, Saral R, Karp JE et al. (1990) Leukemia 4: 313–315

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Prentice, H.G. (1992). Understanding the Mechanisms of Cure in Acute Myeloblastic Leukaemia: Towards a Modern Immunotherapy. In: Hiddemann, W., Büchner, T., Wörmann, B., Plunkett, W., Keating, M., Andreeff, M. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76591-9_98

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76591-9_98

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53949-0

  • Online ISBN: 978-3-642-76591-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics